abstract |
Described are tablets containing hydrolytically stable disodium salt compositions (6- (5-fluoro-2- (3,4,5-trimethoxyphenylamino) pyrimidin-4-ylamino) -2,2-dimethyl-3-oxo-2H-pyrido [ 3,2-b] [1,4] oxazin-4 (3H) -yl) methylphosphate (compound 1) obtained by wet granulation. |